Defining the Communication Between Agonist and Coactivator Binding in the Retinoid X Receptor a Ligand Binding Domain
News Nov 06, 2013
Background: Some retinoid X receptor (RXR) agonists have potential as cancer drugs.
Results: Structures of RXR in complex with two different agonists show similar folds. Dynamics analysis reveals unique ligand-induced dynamics in helices 3, 11, and 12.
Conclusion: Two networks of interactions which connect RXR agonists to coactivator binding are defined.
Significance: Recognizing common conformational changes and distinguishing dynamics of RXR-selective agonists is needed for advances in drug design.
This article was published online in The Journal of Biological Chemistry and is free to access.
New Opportunities for Type 2 Diabetes Drug Discovery: Researchers Determine Glucagon Receptor StructureNews
Complex structure of a class B GPCR bound to an analogue of its endogenous ligand ignites new excitement in GPCR research.READ MORE
Innovative ALS Therapy Startup Wins Golden Ticket Funding From AmgenNews
Amgen and LabCentral have announced that Kernal Biologics Inc. and QurAlis have won the Amgen Golden Ticket at LabCentral.READ MORE
MiNT Protein: A New Target to Treat Cancer, Diabetes and Other Diseases?News
A two-faced protein in a chain that regulates iron and other elements in cells could provide a new target to treat cancer, diabetes and other diseases.READ MORE